LLY · Insider Trading

Eli Lilly & Co.

Every open-market purchase and sale reported by LLY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
5
code S
Reporting Insiders
25
current holders
LLY — Recent Form 4 Transactions (latest 2026-10-20)
FiledInsiderRole TypeSharesValue
2026-10-20 Gabrielle Sulzberger Director A +3 +$4.96K
2026-10-20 J Erik Fyrwald Director A +7 +$9.92K
2026-10-20 Ralph Alvarez Director A +10 +$12.42K
2026-10-20 Juan R Luciano Director A +12 +$15.92K
2026-09-22 Gabrielle Sulzberger Director A +4 +$4.96K
2026-09-22 Juan R Luciano Director A +13 +$15.92K
2026-09-22 J Erik Fyrwald Director A +8 +$9.92K
2026-09-22 Ralph Alvarez Director A +10 +$12.42K
2026-09-11 Melissa Seymour EVP, Global Quality G −29 —
2026-09-04 Eric Dozier EVP, Chief People Officer G −216 —
2026-09-04 Edgardo Hernandez EVP & Pres., Mfg. Operations G −13 —
2026-08-18 Juan R Luciano Director A +13 +$15.92K
2026-08-18 J Erik Fyrwald Director A +8 +$9.92K
2026-08-18 Gabrielle Sulzberger Director A +4 +$4.96K
2026-08-18 Ralph Alvarez Director A +10 +$12.42K
2026-08-18 Patrik Jonsson EVP & President, LLY Int'l Sell −6,500 −$7.64M
2026-08-11 Donald A Zakrowski SVP, Finance, & CAO Sell −2,000 −$2.37M
2026-08-10 Anat Hakim EVP, GC & Secretary Sell −5,000 −$5.95M
2026-08-03 Melissa Seymour EVP, Global Quality MIXED +542 −$504.00K
2026-07-21 Ralph Alvarez Director A +10 +$12.42K
2026-07-21 Juan R Luciano Director A +13 +$15.92K
2026-07-21 J Erik Fyrwald Director A +8 +$9.92K
2026-07-21 Gabrielle Sulzberger Director A +4 +$4.96K
2026-06-16 J Erik Fyrwald Director A +8 +$9.92K
2026-06-16 Juan R Luciano Director A +14 +$15.92K
2026-06-16 Ralph Alvarez Director A +10 +$12.42K
2026-06-16 Gabrielle Sulzberger Director A +4 +$4.96K
2026-06-11 Ilya Yuffa EVP&Pres, LLY USA&Global Capab Sell −2,500 −$2.88M
2026-05-19 Ralph Alvarez Director A +12 +$12.42K
2026-05-19 J Erik Fyrwald Director A +10 +$9.92K
2026-05-19 Juan R Luciano Director A +16 +$15.92K
2026-05-19 Gabrielle Sulzberger Director A +5 +$4.96K
2026-05-07 LILLY ENDOWMENT INC — Sell −15,828 −$15.75M
2026-04-21 Ralph Alvarez Director A +13 +$12.42K
2026-04-21 J Erik Fyrwald Director A +10 +$9.92K
2026-04-21 Juan R Luciano Director A +17 +$15.92K
2026-04-21 Gabrielle Sulzberger Director A +5 +$4.96K
2026-03-17 Ralph Alvarez Director A +12 +$12.42K
2026-03-17 J Erik Fyrwald Director A +10 +$9.92K
2026-03-17 Juan R Luciano Director A +16 +$15.92K
2026-03-17 Gabrielle Sulzberger Director A +5 +$4.96K
2026-02-19 Eric Dozier EVP, Chief People Officer G −481 —
2026-02-18 Adrienne S Brown EVP, President LLY Imm MIXED +221 −$176.76K
2026-02-18 Kenneth L. Custer EVP & President, Card Met Hlth MIXED +115 −$94.96K
2026-02-18 Lucas Montarce EVP & CFO MIXED +208 −$166.12K
2026-02-18 Donald A Zakrowski SVP, Finance, & CAO MIXED +102 −$84.82K
2026-02-18 Ralph Alvarez Director A +11 +$12.42K
2026-02-18 J Erik Fyrwald Director A +9 +$9.92K
2026-02-18 Juan R Luciano Director A +15 +$15.92K
2026-02-18 Gabrielle Sulzberger Director A +4 +$4.96K
LLY — Current Insider Holders
InsiderRole Shares HeldValue
LILLY ENDOWMENT INC 10%+ Owner 91,883,358 $117.01B
David A Ricks President, Chair, and CEO 579,023 $737.36M
Daniel Skovronsky EVP, CS&PO & Pres. LRL 162,781 $207.30M
J Erik Fyrwald Director 75,544 $96.20M
Anne E. White EVP & Pres, Lilly Neuroscience 74,209 $94.50M
Ralph Alvarez Director 56,606 $72.09M
Patrik Jonsson EVP & President, LLY Int'l 54,779 $69.76M
Edgardo Hernandez EVP & Pres., Mfg. Operations 46,956 $59.80M
Anat Hakim EVP, GC & Secretary 38,687 $49.27M
Jacob Van Naarden EVP,Pres LLY Oncology&HdCorpBD 31,928 $40.66M
Ilya Yuffa EVP&Pres, LLY USA&Global Capab 29,804 $37.95M
Diogo Rau EVP & CIDO 26,396 $33.61M
Katherine Baicker Director 23,502 $29.93M
William G Kaelin Jr Director 21,836 $27.81M
Juan R Luciano Director 16,969 $21.61M
Lucas Montarce EVP & CFO 16,258 $20.70M
Eric Dozier EVP, Chief People Officer 14,652 $18.66M
Kenneth L. Custer EVP & President, Card Met Hlth 10,140 $12.91M
Jamere Jackson Director 9,635 $12.27M
Karen Walker Director 6,248 $7.96M
Adrienne S Brown EVP, President LLY Imm 5,312 $6.77M
Kimberly H Johnson Director 3,264 $4.16M
Donald A Zakrowski SVP, Finance, & CAO 3,260 $4.15M
Gabrielle Sulzberger Director 3,016 $3.84M
Mary Lynne Hedley Director 2,350 $2.99M
LLY Insider Trading FAQ
Who are the insiders at LLY?
25 officers, directors and 10%+ beneficial owners currently report holdings in LLY via SEC Form 4.
Are LLY insiders buying or selling?
Across the 50 most recent Form 4 filings for LLY, 0 were open-market purchases (code P) and 5 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is LLY insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent LLY filing is dated 2026-10-20.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the LLY quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.